Organto Foods reports first-half 2026 results and announces leadership change
Organto Foods has provided an operations update, reported first-half 2026 performance figures and outlined changes involving its leadership team and annual corporate filings.
Organto Foods Inc. (TSXV:OGO)(OTCQX:OGOFF)(FSE:OGF0) has issued an update covering its first-half 2026 performance, an upcoming investor conference presentation, a change in Bob Kouw’s role and the filing of its Annual Information Form for the year ended December 31, 2025.
The company reported record first-half results for 2026, including a 73% increase in sales and a 108% increase in adjusted gross margin. Organto also reported positive EBITDA in both the first and second quarters.
Organto said its annualized sales run rate was over $100 million. The company also cited inflationary pressures and significant geopolitical factors affecting global supply chains.
Steve Bromley, Organto’s Co-Chair and CEO, said the company believes its business activity has continued into the second half of the year and that it believes it will achieve record results for the third quarter and beyond. This is a forward-looking statement from management and is subject to the assumptions and risks outlined in the company’s release.
Bromley is scheduled to present at the Planet MicroCap Toronto 2026 Conference at the Arcadian Loft in Toronto on Wednesday, October 28, 2026, at 10:00 a.m. Eastern Time.
Organto also plans to hold in-person meetings with registered conference attendees on October 28th and October 29th.
Bob Kouw will leave Organto’s Leadership Team and move from his position as COO, M&A and Operational Treasury, to a Strategic Advisor role effective November 1, 2026.
Following the company’s reorganization announced on March 31, 2026, Kouw had focused on strategic M&A and business development after his former operational responsibilities were transferred to other members of the Leadership Team. In his new role, he will continue supporting Organto in those areas.
Organto said it has filed its Annual Information Form for the year ended December 31, 2025, and intends to continue making the filing annually. The company described the filing as part of its corporate governance practices.
The update refers to adjusted gross margin and EBITDA, which Organto identifies as non-IFRS financial measures. The company said these measures do not have standardised meanings under IFRS, should not be viewed separately from its IFRS financial information or used as substitutes for it, and may not be comparable with measures reported by other issuers.
Organto Foods provided an update on its current operations and business matters, announced Steve Bromley’s presentation at the Planet MicroCap Toronto 2026 Conference, outlined Bob Kouw’s transition to a Strategic Advisor role, and reported the filing of its Annual Information Form for the year ended December 31, 2025.
Steve Bromley, Co-Chair and CEO of Organto Foods, is scheduled to present at the Arcadian Loft in Toronto on Wednesday, October 28, 2026, at 10:00 a.m. Eastern Time. The Company will also host in-person meetings with registered attendees on October 28th and October 29th.
The live presentation can be accessed through the Planet MicroCap Toronto 2026 Conference website at https://www.meetmax.com/sched/event_136811/conference_home.html. If investors cannot attend live, the presentation will be available on the conference event platform on the HOME PAGE link under the tab “Agenda”.
Organto Foods reported record first half results in 2026, with sales up 73% and adjusted gross margin up 108%. The Company also reported positive EBITDA in both the first and second quarters.
Organto Foods reported an annualised sales run rate of over $100 million. The figure was included in Steve Bromley’s comments on the Company’s first-half 2026 performance.
Steve Bromley said Organto Foods’ momentum had carried into the back half of the year and that the Company believes it will continue to achieve record results for the third quarter and beyond. This is management’s forward-looking view and is subject to the risks and assumptions described in the release.
Organto Foods said inflationary pressures and significant geopolitical factors were impacting global supply chains. The release also identifies risks including inclement weather, unfavourable growing conditions, low crop yields, variations in crop quality, spoilage, import and export laws, and transportation costs and risks.
Organto Foods is a Canadian-headquartered company supplying certified organic and fairtrade produce to leading international retailers. It manages global sourcing, logistics and distribution through an integrated, capital-efficient model connecting growers and consumers.
Steve Bromley said Organto Foods’ balance sheet remains strong and that the Company continues to assess opportunities to responsibly expand its platform. He linked this to Organto’s stated growth objective of building a world-class business in organic and fairtrade foods.
Bob Kouw will step down from Organto Foods’ Leadership Team and transition from COO, M&A and Operational Treasury to a Strategic Advisor role effective November 1, 2026. He will continue supporting the Company with a focus on strategic M&A and business development.
Organto Foods announced that it had filed an Annual Information Form for the year ended December 31, 2025. The completed document is available at www.SEDARplus.ca and on the Company’s website under the Investors tab, and the Company plans to file the form annually going forward.
The release identifies Organto Foods as trading on the TSXV under OGO, on the OTCQX under OGOFF, and on the FSE under OGF0, written as (TSXV:OGO)(OTCQX:OGOFF)(FSE:OGF0). The company description also gives the formats TSX-V: OGO | OTCQX: OGOFF | FSE: OGF0.
Organto Foods referred to adjusted gross profit, adjusted gross margin and EBITDA, noting that these are non-IFRS financial measures. The Company said they are not standardised under IFRS, should not be considered in isolation or as substitutes for IFRS financial information, and may not be comparable with similar measures used by other issuers.